ArzonApteka
PrivateLast Round
Early Funding
Aug 22, 2024
Total Funding Raised
$7.14M
Company Overview
ArzonApteka is a health-tech company that provides a digital platform for searching, comparing, and ordering pharmaceutical products from pharmacies across Uzbekistan.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Retail Technology, Mobile Commerce, E-commerce
Business Model
B2B2C
Customer Profile
Marketplace Commission, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArzonApteka Comparables
Compare ArzonApteka with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Consulta Remédios | 79% | |
| Liki24 | 78% | |
| GoodRx | 61% | |
ArzonApteka Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 22, 2024 |
ArzonApteka Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sturgeon Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors grew 154% MoM, reaching 270.2K.
- Apr 3, 2026
Monthly visitors increased 47% MoM.
ArzonApteka Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArzonApteka's valuation, stock price, and market status.